December 2025

McKesson's Precision Care Companion initiative enhances biomarker testing and targeted therapies in community oncology, improving patient outcomes and cost efficiency.

Members of the CAR T Vision Steering Committee outline key issues around US and EU reimbursement and discuss potential solutions

An AJMC Stakeholder Interchange in Atlanta, Georgia addressed the need for collaboration to bring bispecific antibodies to the outpatient setting in multiple myeloma. Participants discussed the use of prophylactic tocilizumab, emergency department preparation, and health equity challenges.

Experts explore advancements in telehealth and precision medicine, addressing cancer care gaps for rural and underserved populations in oncology.

Medicaid expansion has enhanced cancer care in Louisiana, boosting access to treatments like CAR T-cell therapy and improving breast cancer screening initiatives.

AI and digital tools are reshaping breast cancer care—from screening and trials to remote monitoring and lifestyle support.

Ochsner MD Anderson expands cancer care access in Louisiana through community partnerships, technology, and strong patient-physician relationships.

CMS introduced the GENEROUS Model to reduce Medicaid drug costs, enhance access, and improve health outcomes for beneficiaries starting in 2026.